JPH0430734A - Formation of adventitious root of thyme - Google Patents
Formation of adventitious root of thymeInfo
- Publication number
- JPH0430734A JPH0430734A JP2139379A JP13937990A JPH0430734A JP H0430734 A JPH0430734 A JP H0430734A JP 2139379 A JP2139379 A JP 2139379A JP 13937990 A JP13937990 A JP 13937990A JP H0430734 A JPH0430734 A JP H0430734A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- thyme
- adventitious roots
- tissue pieces
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007303 Thymus vulgaris Nutrition 0.000 title claims abstract description 22
- 239000001585 thymus vulgaris Substances 0.000 title claims abstract description 22
- 241000246358 Thymus Species 0.000 title claims abstract description 21
- 230000015572 biosynthetic process Effects 0.000 title claims description 3
- 229930192334 Auxin Natural products 0.000 claims abstract description 21
- 239000002363 auxin Substances 0.000 claims abstract description 21
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000004062 cytokinin Substances 0.000 claims abstract description 17
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims abstract description 17
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 claims abstract description 6
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001669 kinetin Drugs 0.000 claims abstract description 6
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000003617 indole-3-acetic acid Substances 0.000 claims abstract description 5
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 claims abstract description 4
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 claims abstract description 4
- 229940023877 zeatin Drugs 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 10
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 claims description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 abstract description 2
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 46
- 210000001519 tissue Anatomy 0.000 description 20
- 239000003375 plant hormone Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229920002148 Gellan gum Polymers 0.000 description 6
- 239000000216 gellan gum Substances 0.000 description 6
- 235000010492 gellan gum Nutrition 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229920001938 Vegetable gum Polymers 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 238000004161 plant tissue culture Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GGZZISOUXJHYOY-UHFFFAOYSA-N 8-amino-4-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C(N)=CC=CC2=C1O GGZZISOUXJHYOY-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- -1 fatty acids Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
この発明は、タイムの組織片から不定根を効率良く形成
(または誘導)する方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for efficiently forming (or inducing) adventitious roots from thyme tissue pieces.
ハーブ系植物は、薬用効果を持つ植物として、生薬、ハ
ーブティー、入浴剤など幅広く利用されている。その中
でも、タイムは、チモール等の有用精油成分を多く含有
しており、頭痛、のどの痛み、風邪、痛風やリューマチ
によるむくみ、座骨神経痛、らい病、てんかん等の治療
薬になると言われ、これらの医薬的特質は実際に証明さ
れている(「ハーブのたのしみJA、ハツトフィールド
著)。Herbal plants are widely used as plants with medicinal effects, such as crude drugs, herbal teas, and bath additives. Among them, thyme contains many useful essential oil components such as thymol, and is said to be a therapeutic agent for headaches, sore throats, colds, swelling caused by gout and rheumatism, sciatica, leprosy, epilepsy, etc. The medicinal properties of herb are actually proven ("Enjoyment of Herbs JA," by Hattfield).
他方、品質の安定な植物原料を大量に入手する方法とし
て、植物の組織培養を工業的に実施するようになってき
ている。たとえば、特開平1−218582号公報では
、セージ、ラヘンダー、ローズマリー、スペアミント、
レモンパームなどの植物カルスを、オーキシンおよびサ
イトカイニンを含む栄養培地で培養後、エタノールの添
加によりカルスより大量の植物精油成分を得るという方
法が示されている。On the other hand, plant tissue culture has come to be practiced industrially as a method for obtaining large quantities of plant materials with stable quality. For example, in Japanese Patent Application Laid-Open No. 1-218582, sage, lahendar, rosemary, spearmint,
A method has been shown in which a plant callus such as lemon palm is cultured in a nutrient medium containing auxin and cytokinin, and then ethanol is added to obtain a large amount of plant essential oil components from the callus.
しかし、いま現在、タイムからの前記有用成分の大量生
産を目的とした組織培養技術はほとんど確立されておら
ず、一般に二次代謝物を蓄積しやすいと言われている不
定根の培養による生産技術はない。However, at present, tissue culture technology for mass production of the above-mentioned useful components from thyme has hardly been established, and production technology using adventitious roots, which are generally said to be prone to accumulating secondary metabolites, has not been established. do not have.
一般に、オーキシン類を培養培地に添加すると、植物組
織片より不定根が容易に形成されると言われているが、
タイムの場合、得られる根は、太くて短く、増殖も遅い
という問題がある。It is generally said that when auxins are added to the culture medium, adventitious roots are more easily formed from plant tissue pieces.
In the case of thyme, the problem is that the roots obtained are thick and short, and the growth is slow.
そこで、この発明は、タイムの組織片から不定根を誘導
する組織培養方法を提供することを課題とする。Therefore, an object of the present invention is to provide a tissue culture method for inducing adventitious roots from thyme tissue pieces.
上記課題を解決するために、この発明は、サイトカイニ
ン類10−s〜10−8Mおよびオーキシン類10−4
〜10−@Mを含む培地を用いてタイムの組織片から不
定根を形成するタイムの不定根形成方法を要旨とする。In order to solve the above problems, the present invention provides cytokinins 10-s to 10-8M and auxins 10-4M.
The gist is a method for forming adventitious roots of thyme from tissue pieces of thyme using a medium containing ~10-@M.
タイム(Thymus vulgaris L、)は、
シソ科の多年草であり、いずれの時期の植物体を使用し
てもよい。タイムの組織片としては、どの部位を使用し
てもよいが、たとえば、葉と葉の間の茎の部分、葉を含
む茎の部分などが使用される。Thymus (Thymus vulgaris L) is
It is a perennial plant belonging to the Lamiaceae family, and plants of any season may be used. Any part of the thyme tissue may be used, but for example, the part of the stem between the leaves, the part of the stem containing the leaves, etc. are used.
この発明では、培地は、たとえば、無機成分、炭素源お
よび植物ホルモンを必須成分とし、更に必要に応じてビ
タミン類やアミノ酸類を添加した培地が使用される。In the present invention, a medium containing, for example, inorganic components, carbon sources, and plant hormones as essential components, and further containing vitamins and amino acids as necessary, is used.
使用する培地は、植物ホルモンである、サイトカイニン
類およびオーキシン類を含んでいる必要がある。サイト
カイニン類が含まれオーキシン類が含まれていないと発
根せずカルスのみが形成される。また、上述したように
、オーキシン類が含まれサイトカイニン類が含まれてい
なくても発根するが、両者を下記特定濃度で併用する場
合に比べて、太くて短い根が形成され、また、成長速度
も遅い。The medium used must contain cytokinins and auxins, which are plant hormones. If cytokinins are present but auxins are not present, rooting will not occur and only callus will form. In addition, as mentioned above, roots will form even if auxins are included and cytokinins are not included, but thicker and shorter roots will be formed and growth will be faster than when both are used together at the specific concentrations listed below. It's also slow.
サイトカイニン類としては、たとえば、ベンジルアデニ
ン、カイネチン、ゼアチンなどが挙げられ、いずれか1
つまたは2以上が使用されるが、ここに挙げたものに限
定されない。オーキシン類としては、たとえば、インド
ール酢酸、2.4ジクロロフエノキシ酢酸(2,4−D
とも言う)、ナフタレン酢酸などが挙げられ、いずれが
1つまたは2L)、上が使用されるが、ここに挙げたも
のに限定されない。Examples of cytokinins include benzyladenine, kinetin, zeatin, etc.
One or more may be used, but are not limited to those listed here. Examples of auxins include indole acetic acid, 2.4 dichlorophenoxy acetic acid (2,4-D
), naphthalene acetic acid, etc., any one or 2 L) may be used, but are not limited to those listed here.
培地中のサイトカイニン類の濃度は10−s〜10−8
M、好ましくは10−6〜10−’Mである。培地中の
オーキシン類の濃度は10−4〜10−@M、好ましく
は10−5〜10−’Mである。培地中のサイトカイニ
ン類の濃度が前記範囲の上限を上回ると細胞が褐変化し
て死亡するおそれがあり、下型を下回ると発根が起こら
ないおそれがある。オーキシン類の濃度が前記範囲を外
れた場合も同様である。The concentration of cytokinins in the medium is 10-s to 10-8
M, preferably 10-6 to 10-'M. The concentration of auxins in the medium is 10-4 to 10-@M, preferably 10-5 to 10-'M. If the concentration of cytokinins in the medium exceeds the upper limit of the above range, cells may turn brown and die, and if it is below the lower type, rooting may not occur. The same applies when the concentration of auxins is outside the above range.
培地の無機成分として、たとえば、窒素、リン、カリウ
ム、ナトリウム、カルシウム、マグネシウム、鉄、マン
ガン、亜鉛、モリブデン、銅、コバルト、イオウ、ホウ
素、塩素、ヨウ素等の元素を含む無機塩を挙げることが
できる。具体的にはたとえば、硝酸カリウム、硝酸ナト
リウム、硝酸アンモニウム、塩化カリウム、塩化カルシ
ウム、リン酸二水素カリウム、リン酸二水素ナトリウム
、硫酸マグネシウム、硫酸アンモニウム、硫酸ナトリウ
ム、硫酸第一鉄、硫酸第二鉄、硫酸マンガン、硫酸銅、
硫酸亜鉛、モリブデン酸ナトリウム、ヨウ化カリウム、
ホウ酸、塩化コバルト等の化合物を例示できる。Inorganic components of the medium include, for example, inorganic salts containing elements such as nitrogen, phosphorus, potassium, sodium, calcium, magnesium, iron, manganese, zinc, molybdenum, copper, cobalt, sulfur, boron, chlorine, and iodine. can. Specifically, for example, potassium nitrate, sodium nitrate, ammonium nitrate, potassium chloride, calcium chloride, potassium dihydrogen phosphate, sodium dihydrogen phosphate, magnesium sulfate, ammonium sulfate, sodium sulfate, ferrous sulfate, ferric sulfate, sulfuric acid. manganese, copper sulfate,
Zinc sulfate, sodium molybdate, potassium iodide,
Examples include compounds such as boric acid and cobalt chloride.
前記培地の炭素源としては、たとえば、ショ糖等の炭水
化物とその誘導体、脂肪酸等の有機酸およびエタノール
等の1級アルコールを例示できる前記培地のビタミン類
としては、たとえば、ビオチン、チアミン、ピリドキシ
ン、ピリドキサール、ピリドキサミン、パントテン酸カ
ルシウム、アスコルビン酸、イノシトール、ニコチン酸
、ニコチン酸アミド等が例示できる。Examples of carbon sources in the medium include carbohydrates such as sucrose and derivatives thereof, organic acids such as fatty acids, and primary alcohols such as ethanol. Examples of vitamins in the medium include biotin, thiamine, pyridoxine, Examples include pyridoxal, pyridoxamine, calcium pantothenate, ascorbic acid, inositol, nicotinic acid, and nicotinamide.
前記培地のアミノ酸類としては、たとえば、グリシン、
アラニン、グルタミン酸、システィンおよびフェニルア
ラニンなどを例示できる。Examples of amino acids in the medium include glycine,
Examples include alanine, glutamic acid, cysteine and phenylalanine.
前記培地は、通常は、前記無機成分を約10−’Mない
し約0.1M、前記炭素源を約10g/lないし約50
g / A’、前記ビタミン類を約0.1■/lない
し約150■/I!、前記アミノ酸を0ないし約1g/
l、および、植物ホルモン類を前記の濃度で含ませて使
用する。これらの成分が、それぞれ、前記の範囲の上限
よりも多いと、細胞が褐変化して死亡するおそれがあり
、下限よりも少ないかゼロだと、細胞の生育が悪くなる
おそれがある。しかし、前記植物ホルモン類以外の成分
の種類や量などは特に限定されるものではない。The medium usually contains the inorganic component from about 10-'M to about 0.1M and the carbon source from about 10-'M to about 50g/l.
g/A', the above vitamins from about 0.1 ■/l to about 150 ■/I! , 0 to about 1 g of the amino acid/
1 and plant hormones at the above-mentioned concentrations. If each of these components exceeds the upper limit of the above-mentioned range, the cells may turn brown and die, while if the content is less than the lower limit or is zero, the growth of the cells may deteriorate. However, the types and amounts of components other than the plant hormones are not particularly limited.
この発明のタイムの組織片の培養に用いられる前記培地
として具体的には、従来から知られている植物の組織培
養に用いられている培地、たとえば、ムラシゲ・スクー
グの培地、リンスマイヤー・スクーグの培地、ホワイト
の培地、ガンボルグのB−5培地、ニッチ・ニッチの培
地等に前記した炭素源および植物ホルモン類を添加し、
更に必要に応じて前記のビタミン類およびアミノ酸類を
添加して調製される培地を例示できるが、この発明では
特にムラシゲ・スクーグの培地を用いて調製される培地
が望ましい。Specifically, the medium used for culturing the thyme tissue pieces of the present invention may be a conventionally known culture medium used for plant tissue culture, such as Murashige-Skoog's medium or Linsmeyer-Skoog's medium. Add the carbon source and plant hormones described above to a medium, White's medium, Gamborg's B-5 medium, Niche Niche medium, etc.
Furthermore, a medium prepared by adding the above-mentioned vitamins and amino acids as necessary can be exemplified, but in this invention, a medium prepared using a Murashige-Skoog medium is particularly desirable.
この発明では、前記培地は、たとえば、寒天等の多糖類
を0.1〜1重量%含有させた固体培地として使用され
る。多糖類がこの範囲の上限を越えると細胞がひからび
て死亡するおそれがあり、下限を下回ると培地が固まら
ないおそれがある。In this invention, the medium is used as a solid medium containing, for example, 0.1 to 1% by weight of a polysaccharide such as agar. If the polysaccharide exceeds the upper limit of this range, the cells may wither and die, and if it falls below the lower limit, the medium may not solidify.
タイムの組織片を培養するための培地として、サイトカ
イニン類およびオーキシン類を上記特定の濃度で含む培
地を用いることにより、タイムの不定根が形成される。Adventitious roots of thyme are formed by using a medium containing cytokinins and auxins at the above-described specific concentrations as a medium for culturing thyme tissue pieces.
しかも、オーキシン類を用い、サイトカイニン類を用い
ない場合に比べて、細くて長く、増殖も早い。Moreover, they are thinner, longer, and multiply faster than when auxins are used and cytokinins are not used.
以下に、この発明の具体的な実施例および比較例を示す
が、この発明は下記実施例に限定されない。Specific examples and comparative examples of the present invention are shown below, but the present invention is not limited to the following examples.
一実施例1
100d容培養シヤーレ中に、ベンジルアデニン10−
’M、ナフタレン酢酸10−%Mを含有するムラシゲス
クーグ培地〔ショ糖3重量%、植物ガム質(ジェランガ
ム)0.3重量%含有〕の固体培地を作製し、この培地
にタイムの茎(葉と葉の間の部分、または、葉を含む部
分。長さ1〜2cm)を置床して25℃、16時間暗の
条件で15日間培養した。その結果、すべての組織片よ
り多数の不定根が形成された。Example 1 Benzyl adenine 10-
A solid medium of Murashigeskoog medium [containing 3% by weight of sucrose and 0.3% by weight of vegetable gum (gellan gum)] containing 10% M of naphthalene acetic acid was prepared, and this medium was mixed with thyme stems (leaves and The part between the leaves or the part containing the leaves (1 to 2 cm in length) was placed on a bed and cultured at 25° C. for 16 hours in the dark for 15 days. As a result, more adventitious roots were formed than in all tissue pieces.
この培地にジェランガム3000■/ltr加えて固体
培地とする。Gellan gum 3000 μ/ltr is added to this medium to prepare a solid medium.
実施例2一
実施例1で用いたムラシゲスクーグ培地の代わりにB−
5培地〔植物ガム質(ジェランガム)0゜3重量%含有
〕の固体培地を用い、実施例Iと同様の条件で培養を行
った。その結果、90%以上の組織片より多数の不定根
が形成された。Example 2 - Instead of the Murashigeskoog medium used in Example 1, B-
Culture was carried out under the same conditions as in Example I using a solid medium of 5 medium [containing 0.3% by weight of vegetable gum (gellan gum)]. As a result, more adventitious roots were formed in more than 90% of the tissue pieces.
この培地にジェランガム3000■/lを加えて固体培
地とする。3,000 μl/l of gellan gum is added to this medium to prepare a solid medium.
一実施例3−
100−容培養シャーレに、カイネチン101M、2.
4−Dを10−’M金含有るホワイト培地〔ショ糖3重
量%、植物ガム質(ジェランガム)0.3重量%含有〕
の固体培地を作製し、実施例1と同条件で培養を行った
。その結果、90%以上の組織片より多数の不定根が形
成された。Example 3 - In a 100-capacity culture dish, kinetin 101M, 2.
White medium containing 4-D and 10-'M gold [contains 3% by weight of sucrose and 0.3% by weight of vegetable gum (gellan gum)]
A solid medium was prepared and cultured under the same conditions as in Example 1. As a result, more adventitious roots were formed than in more than 90% of the tissue pieces.
この培地にジェランガム3000■/lを加えて固体培
地とする。3,000 μl/l of gellan gum is added to this medium to prepare a solid medium.
実施例4一
実施例3での植物ホルモン組成を、カイネチン104M
、ナフタレン酢酸10−’X3Mにして同条件で培養を
行った結果、すべての組織片より多数の不定根が形成さ
れた。Example 4 - The plant hormone composition in Example 3 was changed to kinetin 104M.
, naphthaleneacetic acid 10-'×3M and cultured under the same conditions, a large number of adventitious roots were formed from all the tissue pieces.
一実施例5一
実施例3で用いたホワイト培地の代わりにムラシゲスク
ーグ培地を用いた培地で、実施例3と同様の条件で培養
を行った結果、すべての組織片より多数の不定根が形成
された。Example 5 As a result of culturing under the same conditions as in Example 3 using a medium using Murashige-Skoog medium instead of the White medium used in Example 3, a large number of adventitious roots were formed from all tissue pieces. .
一実施例6一
実施例1においてサイトカイニン類としてゼアチン10
4M、オーキシン類としてインドール酢酸10−’Mを
用いたこと以外は実施例1と同様にした結果、90%以
上の組織片より多数の不定根が形成された。Example 6 Zeatin 10 as a cytokinin in Example 1
4M and 10-'M indoleacetic acid as the auxin. As a result, a large number of adventitious roots were formed from more than 90% of the tissue pieces.
一実施例7
実施例1においてサイトカイニン類の濃度を10−@M
、および、オーキシン類の濃度を10−@Mとしたこと
以外は実施例1と同様にした結果、70%以上の組織片
より多数の不定根が形成された一比較例1
実施例1において植物ホルモン組成を、ヘンシルアデニ
ン10−’M、2.4−Dを10−’Mにして同条件で
培養を行った結果、すべての組織片より少しだけカルス
化が起こったが、間もなく褐変化してしまった。Example 7 In Example 1, the concentration of cytokinins was changed to 10-@M.
A comparative example 1 in which a large number of adventitious roots were formed from 70% or more of the tissue pieces as a result of the same procedure as in Example 1 except that the concentration of auxins was 10-@M. As a result of culturing under the same conditions with the composition of hensyl adenine at 10-'M and 2.4-D at 10-'M, a little callus formation occurred compared to all the tissue pieces, but it soon turned brown. Oops.
比較例2
実施例3での植物ホルモン組成を、カイネチン10−’
M、インドール酢酸10−8Mにして同条件で培養を行
った結果、どの組織片も褐変化してしまい、不定根は形
成されなかった。Comparative Example 2 The plant hormone composition in Example 3 was changed to kinetin 10-'
As a result of culturing under the same conditions with M and indole acetic acid at 10-8 M, all tissue pieces turned brown and no adventitious roots were formed.
−比較例3一
実施例1においてサイトカイニン類の濃度を10−8M
、および、オーキシン類の濃度を101Mとしたこと以
外は実施例1と同様にした結果、どの組織片も褐変化し
て死亡した。- Comparative Example 3 - In Example 1, the concentration of cytokinins was 10-8M.
As a result of carrying out the same procedure as in Example 1 except that the concentration of auxin and auxin was 101M, all the tissue pieces turned brown and died.
なお、植物ホルモンとして号イトカイニン類を含まずオ
ーキシン類のみを含む培地を用いて培養した不定根は、
上記実施例1〜7で形成された不定根に比べて、太くて
短く、増殖も遅い。In addition, adventitious roots cultured using a medium containing only auxins and no itokainins as plant hormones,
Compared to the adventitious roots formed in Examples 1 to 7 above, they are thicker, shorter, and grow slower.
この発明にかかるタイムの不定根形成方法は、以上に述
べたように、タイムの組織片を容易に発根させることが
できる。また、この発明によれば、植物ホルモンとして
オーキシン類のみを含む培地を用いる場合に比べて、不
定根の形成が良好である。これにより、タイムからの有
用物を大量に得ることが期待される。As described above, the method for forming adventitious roots of thyme according to the present invention can easily root thyme tissue pieces. Furthermore, according to the present invention, adventitious roots can be formed better than when using a medium containing only auxins as plant hormones. This is expected to yield a large amount of useful material from thyme.
代理人 弁理士 松 本 武 彦
手続補正書(自発
1゜
2゜
3゜
4゜
1呵牛の耘
特願平02−139379号
発明の名称
タイムの不定根形成方法
補正をする者
事件との関係 特許出願人
住 所 大阪府門真市大字門真1048番地
名 称(583)松下電工株式会社Agent Patent Attorney Takehiko Matsumoto Procedural Amendment (Spontaneous 1゜2゜3゜4゜1) Name of Invention Patent Application No. 02-139379 Relation to the case of the person amending the method of forming indefinite roots of time Patent Applicant Address 1048 Kadoma, Kadoma City, Osaka Name (583) Matsushita Electric Works Co., Ltd.
Claims (1)
よびオーキシン類10^−^4〜10^−^8Mを含む
培地を用いてタイムの組織片から不定根を形成するタイ
ムの不定根形成方法。 2 サイトカイニン類がベンジルアデニン、カイネチン
およびゼアチンからなる群の中から選ばれる少なくとも
1つであり、オーキシン類がインドール酢酸、2,4−
ジクロロフェノキシ酢酸およびナフタレン酢酸からなる
群の中から選ばれる少なくとも1つである請求項1記載
のタイムの不定根形成方法。[Scope of Claims] 1. Thyme in which adventitious roots are formed from thyme tissue pieces using a medium containing 10^-^5 to 10^-^8M of cytokinins and 10^-^4 to 10^-^8M of auxins. adventitious root formation method. 2 The cytokinin is at least one selected from the group consisting of benzyladenine, kinetin, and zeatin, and the auxin is indoleacetic acid, 2,4-
The method for forming adventitious roots of thyme according to claim 1, wherein at least one root is selected from the group consisting of dichlorophenoxyacetic acid and naphthaleneacetic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2139379A JPH0430734A (en) | 1990-05-28 | 1990-05-28 | Formation of adventitious root of thyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2139379A JPH0430734A (en) | 1990-05-28 | 1990-05-28 | Formation of adventitious root of thyme |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0430734A true JPH0430734A (en) | 1992-02-03 |
Family
ID=15243951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2139379A Pending JPH0430734A (en) | 1990-05-28 | 1990-05-28 | Formation of adventitious root of thyme |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0430734A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159473A (en) * | 1998-06-24 | 2000-12-12 | Botanical Laboratories, Inc. | Sore throat spray |
KR100429416B1 (en) * | 2000-07-03 | 2004-04-29 | 린나이코리아 주식회사 | grill |
CN102511891A (en) * | 2012-01-11 | 2012-06-27 | 延安常泰药业有限责任公司 | Application of Thymus mongolicus extracting solution to preparing beverage for preventing colds |
-
1990
- 1990-05-28 JP JP2139379A patent/JPH0430734A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159473A (en) * | 1998-06-24 | 2000-12-12 | Botanical Laboratories, Inc. | Sore throat spray |
KR100429416B1 (en) * | 2000-07-03 | 2004-04-29 | 린나이코리아 주식회사 | grill |
CN102511891A (en) * | 2012-01-11 | 2012-06-27 | 延安常泰药业有限责任公司 | Application of Thymus mongolicus extracting solution to preparing beverage for preventing colds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0430734A (en) | Formation of adventitious root of thyme | |
JPH05219974A (en) | Production of tropane alkaloid | |
EP1712131A2 (en) | Formulations comprising indole and/or indole derivatives for increasing the capacity of plants to assimilate mineral nutrients. | |
JPS619227A (en) | Tissue culture of buttercup plant | |
CN105724152A (en) | Rapid Cirmamonun Camphora growing method | |
JPH02283223A (en) | Tissue culture of hiba arborvitae plant | |
JPH02171181A (en) | Method of tissue culture for hiba arborvitae | |
JPS6384497A (en) | Production of tropan based alkaloid | |
JPS6232880A (en) | Tissue culture of ranunculaceae family plant | |
JPS63129989A (en) | Production of tropane alkaloid | |
JPS63167790A (en) | Tissure culture | |
JPH04108392A (en) | Production of tropones | |
JPH01300890A (en) | Cell capable of highly producing tropane-based alkaloid and production of said cell | |
CA1134764A (en) | Producing codeine from papaver cell cultures | |
JPH04197186A (en) | Production of tropolones | |
JPS63129982A (en) | Method for carrying out tissue culture of plant | |
JPS6269985A (en) | Method for tissue culture for safflower | |
JPS60227673A (en) | Method for selecting cultivated cell of thalictrum thunbergii dc. | |
CN108947733A (en) | A kind of wide yulan plantation dedicated fertilizer that fertilizer efficiency is permanent | |
JPS63116691A (en) | Tissue cultivation method for plant | |
Kannan et al. | Abscisic acid induced root tip swelling in Sorghum | |
JPH01240194A (en) | Production of tropane-based alkaloid | |
JPH0398579A (en) | Tissue culture of arborvitae plant | |
JPS63245687A (en) | Production of protopine | |
JPH0251598B2 (en) |